Bosh sahifaAGIO • BMV
add
Agios Pharmaceuticals Inc
Yopilish kursi
983,02 $
Yillik diapazon
397,93 $ - 983,02 $
Bozor kapitalizatsiyasi
3,18 mlrd USD
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 8,96 mln | 21,15% |
Joriy xarajat | 38,54 mln | 49,24% |
Sof foyda | 947,92 mln | 1 137,97% |
Sof foyda marjasi | 10,57 ming | 956,76% |
Har bir ulushga tushum | -1,47 | 10,66% |
EBITDA | -101,47 mln | -2,21% |
Amaldagi soliq stavkasi | 5,31% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,00 mlrd | 55,18% |
Jami aktivlari | 1,79 mlrd | 77,89% |
Jami passivlari | 165,12 mln | 37,13% |
Umumiy kapital | 1,63 mlrd | — |
Tarqatilgan aksiyalar | 57,03 mln | — |
Narxi/balansdagi bahosi | 34,46 | — |
Aktivlardan daromad | -20,04% | — |
Kapitaldan daromad | -21,31% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 947,92 mln | 1 137,97% |
Operatsiyalardan naqd pul | -84,22 mln | -36,62% |
Sarmoyadan naqd pul | 250,79 mln | 537,49% |
Moliyadan naqd pul | 2,64 mln | 40,12% |
Naqd pulning sof oʻzgarishi | 169,21 mln | 928,66% |
Boʻsh pul | -3,03 mln | 95,64% |
Haqida
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tashkil etilgan
2008
Sayt
Xodimlar soni
385
